Entry Site Is Associated With Aortic Enlargement After Pre-emptive Endovascular Repair for Uncomplicated Type B Aortic Dissection

医学 围手术期 外科 动脉瘤 主动脉 解剖(医学) 主动脉瘤 心脏病学 内科学
作者
Tomoki Cho,Keiji Uchida,Shota Yasuda,Ryo Izubuchi,Shotaro Kaneko,Atsushi Matsumoto,Makoto Ikematsu,Sho Kakuta
出处
期刊:Journal of Endovascular Therapy [SAGE Publishing]
卷期号:31 (5): 949-954 被引量:2
标识
DOI:10.1177/15266028231161224
摘要

OBJECTIVES: We aimed to examine the mid-term results corresponding to the entry site in patients who underwent pre-emptive thoracic endovascular aortic aneurysm repair (TEVAR) for uncomplicated type B aortic dissection (TBAD). METHODS: We included 27 patients who underwent pre-emptive TEVAR for uncomplicated TBAD between September 2014 and December 2019. We divided the patients into 2 groups depending on the proximal landing zone (zone 2 group, zone ≥3 group) and retrospectively analyzed the risk of all-cause and aorta-related mortality, aortic events (rupture, open conversion, and secondary intervention), and aortic enlargement (≥5 mm). RESULTS: The median age of the patients was 53 (47-65) years. The median duration from the onset of uncomplicated TBAD to TEVAR was 43 (30-99) days, and the median follow-up duration was 48 (36-57) months. The maximum preoperative diameter of the dissected aorta was 40 mm in the zone 2 group and 35 mm in the zone ≥3 group (p=0.134). There was no case of hospital death or spinal cord ischemia; however, there was 1 (3.7%) case of perioperative stroke in the zone 2 group. Multivariate analysis of the risk factors for aortic enlargement following pre-emptive TEVAR for uncomplicated TBAD revealed that only zone 2 landing was an independent risk factor. The estimated Kaplan-Meier curve showed a higher rate of aortic enlargement in the zone 2 group at 4 years after pre-emptive TEVAR (46.4% vs 0%, log-rank test; p=0.011). CONCLUSIONS: In this study on TBAD, we found that zone 2 landing was associated with aortic enlargement after pre-emptive TEVAR. In cases where the distance from the left subclavian artery to a major entry point was short, there were more cases of aortic dilatation. CLINICAL IMPACT: The effectiveness of entry closure for type B aortic dissection was demonstrated in the INSTEAD XL trial. The cause of aortic enlargement after pre-emptive endovascular treatment for type B aortic dissection remains controversial. In the present study, zone 2 landing was a risk factor for aortic enlargement after pre-emptive thoracic endovascular aortic aneurysm repair (TEVAR) for uncomplicated type B dissection. Patients with zone 2 landing should be closely followed up after pre-emptive TEVAR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小石头完成签到 ,获得积分10
刚刚
milz完成签到,获得积分10
2秒前
称心的以筠完成签到,获得积分10
2秒前
GreenT完成签到,获得积分0
3秒前
xelloss完成签到,获得积分10
3秒前
成就鑫完成签到 ,获得积分10
7秒前
h11的应助被科研通管家采纳,获得10
9秒前
贾贡献的应助被科研通管家采纳,获得10
9秒前
所所的应助被科研通管家采纳,获得10
9秒前
h11的应助被科研通管家采纳,获得10
9秒前
h11的应助被科研通管家采纳,获得10
9秒前
h11的应助被科研通管家采纳,获得10
9秒前
Hello的应助被科研通管家采纳,获得20
9秒前
Luna完成签到 ,获得积分10
9秒前
h11的应助被科研通管家采纳,获得10
10秒前
h11的应助被科研通管家采纳,获得10
10秒前
10秒前
10秒前
h11的应助被科研通管家采纳,获得10
10秒前
Green完成签到,获得积分10
12秒前
SCI的芷蝶完成签到 ,获得积分10
13秒前
林美芳完成签到 ,获得积分10
14秒前
科研顺利完成签到,获得积分10
15秒前
LiYipeiiiiOvO完成签到 ,获得积分10
19秒前
颜颜完成签到,获得积分10
20秒前
n01W97的应助被沭阳检验医师采纳,获得70
23秒前
133完成签到 ,获得积分10
23秒前
千里眼完成签到,获得积分20
24秒前
唠叨的天亦完成签到 ,获得积分10
27秒前
Lily完成签到 ,获得积分10
30秒前
蛋坏坏完成签到 ,获得积分10
31秒前
乐观的黎云完成签到,获得积分10
31秒前
shengjiangtai完成签到 ,获得积分10
35秒前
星辰大海的应助被xiaohululu采纳,获得10
36秒前
沭阳检验医师完成签到,获得积分0
39秒前
syvshc的应助被parantal采纳,获得10
40秒前
meow123完成签到 ,获得积分10
43秒前
纯真的梦竹完成签到,获得积分10
44秒前
吴秋阳完成签到 ,获得积分10
45秒前
可带玉米完成签到,获得积分10
45秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173340
求助须知:如何正确求助?哪些是违规求助? 9565612
关于积分的说明 21780617
捐赠科研通 7767504
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555827
邀请新用户注册赠送积分活动 2476749